Skip to search formSkip to main contentSkip to account menu

PD 140248

Known as: PD-140248, PD140248 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

FluoroquinolonesNaphthyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
PD-140248 (Parke-Davis & Co).
PD-140248 is an isomerase inhibitor and topoisomerase II inhibitor under development by Parke-Davis and Co as a potential… 
1995
1995
In vivo therapeutic efficacies of PD 138312 and PD 140248, two novel fluoronaphthyridines with outstanding gram-positive potency
PD 138312 and PD 140248 are novel broad-spectrum 7-pyrrolidinyl fluoronaphthyridines with a cyclopropyl or a difluorophenyl… 
1995
1995
Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones
The susceptibilities of 120 clinical isolates of Brucella melitensis and 3 reference strains of the same species to six… 
1993
1993
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency
PD 138312 and PD 140248 are new quinolones with high in vitro activities against a wide spectrum of bacterial species, notably… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)